Patient-Friendly Explanation
MC4R agonists are a newer class of weight management medicine that switch on a hunger-control signal in the brain. They are used mainly for people whose appetite regulation is altered by a specific genetic change.
Clinical Definition
MC4R agonists bind the hypothalamic melanocortin-4 receptor within the leptin-melanocortin pathway, reducing food intake and increasing energy expenditure. Setmelanotide is approved for monogenic obesity caused by POMC, PCSK1 or LEPR deficiency and for Bardet-Biedl syndrome, while next-generation oral and injectable MC4R agonists are in trials for common obesity.
Why It Matters
This class treats the biology upstream of appetite, so it works best where obesity has a defined genetic driver. MC4R activation can raise blood pressure and cause skin darkening, so treatment is specialist-led with regular monitoring.